Physical stability, biocompatibility and potential use of hybrid iron oxide-gold nanoparticles as drug carriers

2013 ◽  
Vol 15 (6) ◽  
Author(s):  
Christopher M. Barnett ◽  
Mariana Gueorguieva ◽  
Martin R. Lees ◽  
David J. McGarvey ◽  
Clare Hoskins
Keyword(s):  
Gold Nanoparticles ◽  
Iron Oxide ◽  
Physical Stability ◽  
Drug Carriers ◽  
Potential Use

Optimization of Gold Nanoparticles Synthesis using Design of Experiments Technique

2017 ◽  
Vol 68 (7) ◽  
pp. 1518-1423
Author(s):  
Adina Turcu Stiolica ◽  
Mariana Popescu ◽  
Maria Viorica Bubulica ◽  
Carmen Nicoleta Oancea ◽  
Claudiu Nicolicescu ◽  
...  
Keyword(s):  
Gold Nanoparticles ◽  
Zeta Potential ◽  
Design Of Experiments ◽  
Process Model ◽  
Sodium Citrate ◽  
Drug Carriers ◽  
Chloroauric Acid ◽  
Gold Colloids ◽  
Citrate Concentration ◽  
Vis Spectroscopy

Gold nanoparticles are considered the newest drug carriers for different diseases. Therefore it is appropriate continuous optimization of their preparation. In this study, gold colloids with an average size of 1 - 26 nm were obtained by the reduction of tetrachloroauric acid with trisodium citrate. The nanomaterials were characterized by UV-Vis spectroscopy and dynamic light scattering technique. In addition, zeta potential was measured for samples synthesized in order to determine the stability of the colloids. A Two-level Full Factorial design was chosen to determine the optimum set of process parameters (chloroauric acid concentration and sodium citrate concentration) and their effect on various gold nanoparticles characteristics (size and zeta potential). These effects were quantified using Design of Experiments (DoE) with 5 runs and 1 centerpoint. The selected objective and process model in this investigation are screening and interaction. Findings from this research show that to obtain particles larger than 35 nm, it is recommended to increase sodium citrate concentration, at low chloroauric acid values. These conditions will help to achieve smaller zeta potential, too.

scholarly journals Potential Use of DMSA‐Containing Iron Oxide Nanoparticles as Magnetic Vehicles against the COVID‐19 Disease

2021 ◽  
Vol 6 (31) ◽  
pp. 7931-7935
Author(s):  
Elisama S. Martins ◽  
Ariane Espindola ◽  
Tatiane N. Britos ◽  
Camila Chagas ◽  
Emerson Barbosa ◽  
...  
Keyword(s):  
Iron Oxide ◽  
Iron Oxide Nanoparticles ◽  
Oxide Nanoparticles ◽  
Potential Use

scholarly journals Novel synthesis of superparamagnetic plasmonic core-shell iron oxide-gold nanoparticles

2019 ◽  
Vol 560 ◽  
pp. 85-90 ◽  
Author(s):  
Arne Billen ◽  
Amaury de Cattelle ◽  
Johanna K. Jochum ◽  
Margriet J. Van Bael ◽  
Johan Billen ◽  
...  
Keyword(s):  
Gold Nanoparticles ◽  
Iron Oxide ◽  
Core Shell ◽  
Novel Synthesis

scholarly journals Epigallocatechin Gallate-Gold Nanoparticles Exhibit Superior Antitumor Activity Compared to Conventional Gold Nanoparticles: Potential Synergistic Interactions

Nanomaterials ◽  
2019 ◽  
Vol 9 (3) ◽  
pp. 396 ◽  
Author(s):  
Suhash Chavva ◽  
Sachin Deshmukh ◽  
Rajashekhar Kanchanapally ◽  
Nikhil Tyagi ◽  
Jason Coym ◽  
...  
Keyword(s):  
Gold Nanoparticles ◽  
Antitumor Activity ◽  
Cancer Cells ◽  
Cellular Uptake ◽  
Nuclear Translocation ◽  
Epigallocatechin Gallate ◽  
Drug Carriers ◽  
Water Soluble ◽  
Tetrazolium Salt ◽  
Uptake Studies

Epigallocatechin gallate (EGCG) possesses significant antitumor activity and binds to laminin receptors, overexpressed on cancer cells, with high affinity. Gold nanoparticles (GNPs) serve as excellent drug carriers and protect the conjugated drug from enzymatic metabolization. Citrate-gold nanoparticles (C-GNPs) and EGCG-gold nanoparticles (E-GNPs) were synthesized by reduction methods and characterized with UV-visible spectroscopy, transmission electron microscopy (TEM), and dynamic light scattering (DLS). Cytotoxicity of citrate, EGCG, C-GNPs, and E-GNPs was evaluated by the water-soluble tetrazolium salt (WST-1) assay. Nanoparticle cellular uptake studies were performed by TEM and atomic absorption spectroscopy (AAS). Dialysis method was employed to assess drug release. Cell viability studies showed greater growth inhibition by E-GNPs compared to EGCG or C-GNPs. Cellular uptake studies revealed that, unlike C-GNPs, E-GNPs were taken up more efficiently by cancerous cells than noncancerous cells. We found that E-GNP nanoformulation releases EGCG in a sustained fashion. Furthermore, data showed that E-GNPs induced more apoptosis in cancer cells compared to EGCG and C-GNPs. From the mechanistic standpoint, we observed that E-GNPs inhibited the nuclear translocation and transcriptional activity of nuclear factor-kappaB (NF-κB) with greater potency than EGCG, whereas C-GNPs were only minimally effective. Altogether, our data suggest that E-GNPs can serve as potent tumor-selective chemotoxic agents.

scholarly journals Silica-Coated Magnetic Nanocomposites for Pb2+ Removal from Aqueous Solution

2020 ◽  
Vol 10 (8) ◽  
pp. 2726 ◽  
Author(s):  
Roxana Nicola ◽  
Otilia Costişor ◽  
Mihaela Ciopec ◽  
Adina Negrea ◽  
Radu Lazău ◽  
...  
Keyword(s):  
Iron Oxide ◽  
Adsorption Capacity ◽  
Aqueous Media ◽  
Physical Stability ◽  
Absorption Capacity ◽  
Maximum Adsorption Capacity ◽  
X Ray Diffraction ◽  
Similar Materials ◽  
Ft Ir ◽  
Ft Ir Spectroscopy

Magnetic iron oxide-silica shell nanocomposites with different iron oxide/silica ratio were synthesized and structurally characterized by Fourier transform infrared (FT-IR) spectroscopy, X-ray diffraction (XRD), small-angle neutron scattering, magnetic and N2-sorption studies. The composite that resulted with the best properties in terms of contact surface area and saturation of magnetization was selected for Pb2+ adsorption studies from aqueous media. The material presented good absorption capacity (maximum adsorption capacity 14.9 mg·g−1) comparable with similar materials presented in literature. Its chemico-physical stability and adsorption capacity recommend the nanocomposite as a cheap adsorbent material for lead.

Sign in / Sign up

Export Citation Format

Share Document